Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.
Latency reversal agents (LRA) variably induce HIV re-expression in CD4 T cells but reservoirs are not cleared. Whether HIV epitope presentation is similar between latency reversal and initial infection of CD4 T cells is unknown yet crucial to define immune responses able to detect HIV-infected CD4 T...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-03-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1008442 |
| _version_ | 1819045111298785280 |
|---|---|
| author | Julie Boucau Jishnu Das Neelambari Joshi Sylvie Le Gall |
| author_facet | Julie Boucau Jishnu Das Neelambari Joshi Sylvie Le Gall |
| author_sort | Julie Boucau |
| collection | DOAJ |
| description | Latency reversal agents (LRA) variably induce HIV re-expression in CD4 T cells but reservoirs are not cleared. Whether HIV epitope presentation is similar between latency reversal and initial infection of CD4 T cells is unknown yet crucial to define immune responses able to detect HIV-infected CD4 T cells after latency reversal. HIV peptides displayed by MHC comes from the intracellular degradation of proteins by proteasomes and post-proteasomal peptidases but the impact of LRAs on antigen processing is not known. Here we show that HDAC inhibitors (HDCAi) reduced cytosolic proteolytic activities while PKC agonists (PKCa) increased them to a lesser extent than that induced by TCR activation. During the cytosolic degradation of long HIV peptides in LRA-treated CD4 T cells extracts, HDACi and PKCa modulated degradation patterns of peptides and altered the production of HIV epitopes in often opposite ways. Beyond known HIV epitopes, HDACi narrowed the coverage of HIV antigenic fragments by 8-11aa degradation peptides while PKCa broadened it. LRAs altered HIV infection kinetics and modulated CD8 T cell activation in an epitope- and time-dependent manner. Interestingly the efficiency of endogenous epitope processing and presentation to CD8 T cells was increased by PKCa Ingenol at early time points despite low levels of antigens. LRA-induced modulations of antigen processing should be considered and exploited to enhance and broaden HIV peptide presentation by CD4 T cells and to improve immune recognition after latency reversal. This property of LRAs, if confirmed with other antigens, might be exploited to improve immune detection of diseased cells beyond HIV. |
| first_indexed | 2024-12-21T10:23:23Z |
| format | Article |
| id | doaj.art-1fd33fa231404c10a62066f45a8acdcf |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-12-21T10:23:23Z |
| publishDate | 2020-03-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-1fd33fa231404c10a62066f45a8acdcf2022-12-21T19:07:23ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742020-03-01163e100844210.1371/journal.ppat.1008442Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.Julie BoucauJishnu DasNeelambari JoshiSylvie Le GallLatency reversal agents (LRA) variably induce HIV re-expression in CD4 T cells but reservoirs are not cleared. Whether HIV epitope presentation is similar between latency reversal and initial infection of CD4 T cells is unknown yet crucial to define immune responses able to detect HIV-infected CD4 T cells after latency reversal. HIV peptides displayed by MHC comes from the intracellular degradation of proteins by proteasomes and post-proteasomal peptidases but the impact of LRAs on antigen processing is not known. Here we show that HDAC inhibitors (HDCAi) reduced cytosolic proteolytic activities while PKC agonists (PKCa) increased them to a lesser extent than that induced by TCR activation. During the cytosolic degradation of long HIV peptides in LRA-treated CD4 T cells extracts, HDACi and PKCa modulated degradation patterns of peptides and altered the production of HIV epitopes in often opposite ways. Beyond known HIV epitopes, HDACi narrowed the coverage of HIV antigenic fragments by 8-11aa degradation peptides while PKCa broadened it. LRAs altered HIV infection kinetics and modulated CD8 T cell activation in an epitope- and time-dependent manner. Interestingly the efficiency of endogenous epitope processing and presentation to CD8 T cells was increased by PKCa Ingenol at early time points despite low levels of antigens. LRA-induced modulations of antigen processing should be considered and exploited to enhance and broaden HIV peptide presentation by CD4 T cells and to improve immune recognition after latency reversal. This property of LRAs, if confirmed with other antigens, might be exploited to improve immune detection of diseased cells beyond HIV.https://doi.org/10.1371/journal.ppat.1008442 |
| spellingShingle | Julie Boucau Jishnu Das Neelambari Joshi Sylvie Le Gall Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. PLoS Pathogens |
| title | Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. |
| title_full | Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. |
| title_fullStr | Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. |
| title_full_unstemmed | Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. |
| title_short | Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. |
| title_sort | latency reversal agents modulate hiv antigen processing and presentation to cd8 t cells |
| url | https://doi.org/10.1371/journal.ppat.1008442 |
| work_keys_str_mv | AT julieboucau latencyreversalagentsmodulatehivantigenprocessingandpresentationtocd8tcells AT jishnudas latencyreversalagentsmodulatehivantigenprocessingandpresentationtocd8tcells AT neelambarijoshi latencyreversalagentsmodulatehivantigenprocessingandpresentationtocd8tcells AT sylvielegall latencyreversalagentsmodulatehivantigenprocessingandpresentationtocd8tcells |